# A Study of [13C]Pyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers

> **NCT05041166** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Hyperpolarized [13C] Pyruvate

## Key facts

- **NCT ID:** NCT05041166
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-09-01
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05041166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05041166, "A Study of [13C]Pyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05041166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*